跳至主要内容
临床试验/NL-OMON44723
NL-OMON44723已完成3 期

A multicentre randomised controlled trial to compare the efficacy of ex-vivo oxygenated hypothermic machine perfusion with non-oxygenated hypothermic machine perfusion of kidneys from donors older than 50 years of age and donated after circulatory death. - COPE-COMPARE

niversity of Oxford0 个研究点目标入组 93 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
93

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • For the donor and the donor kidney:
  • - Maastricht category III DCD donors (donors who died after circulatory arrest in a controlled setting)
  • - Aged 50 years or older;For the recipient:
  • - At least 18 years of age
  • - Listed for renal trasplantation due to end stage renal disease on the ET or NHSBT renal waiting list within one of the participating centres
  • - Willingness to comply with the protocol procedures for the duration of the study, including scheduled follow-up visits and examinations

排除标准

  • For the donor and the donor kidney:
  • - Kidney deemed untransplantable by the retrieval surgeon. The contralateral kidney will also not be randomised as the trial is designed as a paired trial;For the recipient:
  • - Scheduled to undergo multi-organ transplantation
  • - Planned dual kidney transplantation

研究者

相似试验